Nations signal support for WHO to stockpile H5N1 vaccineBMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39199.693299.DB (Published 03 May 2007) Cite this as: BMJ 2007;334:925
- John Zarocostas
Rich and developing countries—and vaccine manufacturers—have backed calls by the World Health Organization to try to establish a stockpile of vaccine against the H5N1 strain of influenza in humans. They also want to see a mechanism to ensure wider access to a vaccine by poor nations in the event of a flu pandemic.
At a one day meeting at WHO headquarters in Geneva last week, stakeholders also agreed to the setting up of expert groups to focus on how to create, maintain, fund, and use an H5N1 vaccine stockpile. WHO said that it should continue to consult with appropriate partners and member states on developing a mechanism for access to a vaccine.
“I think it is a very important step in the process towards …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial